Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study

Background This phase I multicenter study was designed to evaluate the safety, tolerability, efficacy, and translational effects on the tumor microenvironment of itacitinib (Janus-associated kinase 1 (JAK1) inhibitor) in combination with epacadostat (indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor) o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Michael Smith, Ignacio Garrido-Laguna, Aung Naing, Lance Leopold, Jason J Luke, Kai Ding, Solmaz Sahebjam, Ryan Geschwindt, John D Powderly, John J Nemunaitis, Aaron S Mansfield, Wells A Messersmith, Patricia M LoRusso, Jordan D Berlin
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2022-03-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/10/3/e004223.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Correction: Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study
Published: (2022-10-01)

Development and validation of a UPLC-MS/MS method for the quantification of parsaclisib and its application to pharmacokinetics and metabolic stability studies
by: Chenjian Zhou, et al.
Published: (2025-07-01)

Phase I dose escalation study of IO-108, an anti-LILRB2 antibody, in patients with advanced solid tumors
by: Ying Zhu, et al.
Published: (2024-11-01)

Exome sequencing shows same pattern of clonal tumor mutational burden, intratumor heterogenicity and clonal neoantigen between autologous tumor and Vigil product
by: David Willoughby, et al.
Published: (2025-03-01)

A sample size analysis of a mathematical model of longitudinal tumor volume and progression‐free survival for Bayesian individual dynamic predictions in recurrent high‐grade glioma
by: Daniel J. Glazar, et al.
Published: (2025-03-01)

Decrease in tumor content assessed in biopsies is associated with improved treatment outcome response to pembrolizumab in patients with rare tumors
by: Sinchita Roy-Chowdhuri, et al.
Published: (2020-05-01)

First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments
by: Aung Naing, et al.
Published: (2024-10-01)

Tumors and Tumor-Related Epilepsy
by: J Gordon Millichap, et al.
Published: (2014-02-01)

Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
by: Mustafa Khasraw, et al.
Published: (2021-07-01)

First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors
by: Toshio Shimizu, et al.
Published: (2024-10-01)

Challenges and opportunities for the next generation of computational tumor models
by: Lance L. Munn, et al.
Published: (2025-07-01)

Challenges and opportunities for the next generation of computational tumor models.
by: Lance L Munn, et al.
Published: (2025-07-01)

Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
by: Jeffrey Schlom, et al.
Published: (2017-01-01)

Characterization of Mortality due to Malignant Tumors
by: María del Carmen Rodríguez Velázquez, et al.
Published: (2020-06-01)

Exploring Tumor Cell–Platelet Biochemical Interactions by Dielectric Measurements of Blood: A Potential Target for Tumor Detection and Staging
by: Annamaria Russo, et al.
Published: (2025-05-01)

Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA
by: Michael J Duffy, et al.
Published: (2018-05-01)

Uterine rupture secondary to undiagnosed placental site trophoblastic tumor: case report
by: Karin Hoch, et al.
Published: (2022-12-01)

Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance
by: Chun Ye, et al.
Published: (2024-12-01)

Intracranial Solitary Fibrous Tumor Masquerading as Meningioma
by: Preeti Joseph John, et al.
Published: (2025-07-01)

Transglutaminase 2 function in glioblastoma tumor efferocytosis
by: Margarita Lui, et al.
Published: (2025-07-01)

Tumor suppressor genes in the tumor microenvironment
by: Bahareh Tabanifar, et al.
Published: (2025-03-01)

Tumor-infiltrating lymphocytes in Wilms tumor
by: Devendra Kumar Yadav, et al.
Published: (2020-01-01)

Challenges in the Management of Massive Carotid Body Tumor
by: Oluwapelumi Olusoga-Peters, et al.
Published: (2024-01-01)

Biomarkers of mRNA vaccine efficacy derived from mechanistic modeling of tumor-immune interactions.
by: Chrysovalantis Voutouri, et al.
Published: (2025-06-01)

A Pott's Puffs Tumor With Coexisting Intracranial Complications
by: Baraka Alphonce, et al.
Published: (2025-06-01)

Beginning and Intermediate Algebra /
by: Messersmith, Sherri
Published: (2007)

Tumor-intrinsic interferon signaling drives pancreatic cancer resistance to tumor mucin1-targeted CAR T cell therapy
by: Ru Zhou, et al.
Published: (2025-08-01)

Solid pseudopapillary tumor of the pancreas (Frantz’s tumor)
by: D. Coco, et al.
Published: (2021-11-01)

Tumor-promoting effect and tumor immunity of SRSFs
by: Shuai Zhang, et al.
Published: (2025-03-01)

Toxin-Based Targeted Therapy for Malignant Brain Tumors
by: Vidyalakshmi Chandramohan, et al.
Published: (2012-01-01)

Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity
by: Akseli Hemminki, et al.
Published: (2020-05-01)

Tumor cell-derived osteopontin promotes tumor fibrosis indirectly via tumor-associated macrophages
by: Yuying Tan, et al.
Published: (2025-04-01)

Expression Quantitative Trait loci (QTL) in tumor adjacent normal breast tissue and breast tumor tissue.
by: Alejandro Quiroz-Zárate, et al.
Published: (2017-01-01)

Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial
by: Mirella Nardo, et al.
Published: (2025-02-01)

The Past and Future of Biomarkers in Testicular Germ Cell Tumors
by: Aditya Bagrodia, Siamak Daneshmand, Liang Cheng, James Amatruda, Matthew Murray, John Lafin
Published: (2020-10-01)

Tumor Microenvironment: Lactic Acid Promotes Tumor Development
by: Yuting Gao, et al.
Published: (2022-01-01)

Tumor vaccines: Toward multidimensional anti-tumor therapies
by: Yuanfang Tan, et al.
Published: (2023-12-01)

Tectal plate tumors Tumores da região tectal
by: Bruno C.R. Lázaro, et al.
Published: (2006-06-01)

Editorial: The tumor microenvironment and immunotherapy for head and neck tumors
by: Yifan Jiang, et al.
Published: (2025-06-01)

Tumor cerebral e gravidez Brain tumors and pregnancy
by: José Carlos Lynch, et al.
Published: (2007-12-01)